HomeHOWL • NASDAQ
add
Werewolf Therapeutics Inc
Previous close
$0.96
Day range
$0.87 - $1.03
Year range
$0.53 - $2.38
Market cap
49.00M USD
Avg Volume
462.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.24M | -40.28% |
Net income | -8.38M | 58.92% |
Net profit margin | — | — |
Earnings per share | -0.17 | 63.04% |
EBITDA | -9.02M | 54.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 57.05M | -48.60% |
Total assets | 69.40M | -45.33% |
Total liabilities | 44.59M | -16.71% |
Total equity | 24.80M | — |
Shares outstanding | 48.60M | — |
Price to book | 1.88 | — |
Return on assets | -31.60% | — |
Return on capital | -46.55% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.38M | 58.92% |
Cash from operations | -11.02M | 22.65% |
Cash from investing | — | — |
Cash from financing | 2.37M | -7.11% |
Net change in cash | -8.66M | 26.80% |
Free cash flow | 20.10M | 355.46% |
About
Founded
2017
Headquarters
Website
Employees
39
